Haakon Sande • 1978 • Bergen • 13 roles • 9 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
H HALSA INVEST AS	Managing Director/CEO	-	1,553,154	100 % directly
F FINNEGAARDEN HOTELL & RESTAURANTER AS	Managing Director/CEO	20,314,721	-	33.33 % indirectly
S SANDE HOLDING AS	Managing Director/CEO	6,138,300	-	33.33 % indirectly
Z ZERACRYL AS	Managing Director/CEO	696,256	2,930,470	6.27 % indirectly
S SANDE HOLDING AS Closed	Managing Director/CEO	5,506,200	5,577,114	-

Boards

Name	Role	Total operating income	Total equity	Shares
H HALSA INVEST AS	Chairman	-	1,553,154	100 % directly
F FINNEGAARDEN HOTELL & RESTAURANTER AS	Board Member	20,314,721	-	33.33 % indirectly
U ULRIKSDAL 1 AS	Board Member	9,639,341	-	33.33 % indirectly
C CRUISESPESIALISTEN AS	Board Member	58,845,701	-	33.33 % indirectly
S SANDE HOLDING AS	Chairman	6,138,300	-	33.33 % indirectly
Z ZERACRYL AS	Board Member	696,256	2,930,470	6.27 % indirectly
S SANDE HOLDING AS Closed	Chairman	5,506,200	5,577,114	-
D DLS AS	Chairman	291,880	10,789,251	-

Last update: Sep 24, 2025

Related industries

2

Services
Tourist
Information and communication
Audio Visual

Direct relationships

5

Shares owned by Haakon Lude Sande

Name	Share class	Total operating income	Total equity	Share
R RECEIPTS AS	Ordinære aksjer	5,544,543	13,083,534	0.7 % directly 0.7 % indirectly 0.62 %
H HALSA INVEST AS	B-aksjer A-aksjer	0 0	1,553,154 1,553,154	99.9 % directly 100 % 0.1 % directly 100 %
F FINNEGAARDEN HOTELL & RESTAURANTER AS		20,314,721	0	33.33 % indirectly
U ULRIKSDAL 1 AS		9,639,341	0	33.33 % indirectly
C CRUISESPESIALISTEN AS		58,845,701	0	33.33 % indirectly
S SANDE HOLDING AS		6,138,300	0	33.33 % indirectly
Z ZERACRYL AS		696,256	2,930,470	6.27 % indirectly
I IMMUNOPHARMA AS	NO0010735335	18,004,610	204,510,579	0.03 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025